Correction: Beyond surface dose: subcutaneous dose escalation underlies TomoTherapy’s skin toxicity in breast radiotherapy
Jiao Xue, Wenjun Zhao, Chenchen Wu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEffects of Radiation Exposure · Chemotherapy-related skin toxicity · Advances in Oncology and Radiotherapy
There was a mistake in the captions of Figures 1 and 3 as published. The captions for Figures 1 and 3 were erroneously swapped. The corrected captions of Figures 1 and 3 appear below.
Figures 1
“Comparison of dosimetric parameters between Synergy and TOMO groups.”
Figures 3
“Comparison of dosimetric parameters within the PTV-projected adjacent superficial tissue (P-PAST) between Synergy and TOMO groups.”
The original version of this article has been updated.